Preclinical to Clinical: The Power of Using Multiple Models and Technologies for Neuroinflammation Drug Discovery

From Preclinical to Clinical: The power of using multiple models and technologies of neuroinflammation for CNS disorder drug discovery.

Unleashing the Potential of Human Tissue Biomarker Analysis with Spatial Epigenetic Profiling

Current Climate: Decoding Therapeutics Financing

UK Life Sciences Creating a Richer National R&D Pipeline

UK Life Sciences – The Future is Bright, Creating a Richer National R&D Pipeline. As we write this in spring 2024, there are signs of recovery, but one that is in its very earliest stages. There is evidence of capital beginning to flow.

Greatly Enhancing the Capacity for Rapid and Comprehensive Mutation Detection

Medicines Discovery Catapult and Xerion Healthcare Secure Funding for Innovative Brain Tumour Treatment